Physician

Alberto Dejesus Cuartas, M.D.

According to 2025 Medicare claims, Alberto Cuartas, M.D. (NPI: 1740381169) practices medical oncology, with the plurality of this provider's patient population coming from Williamson, IL. This provider's primary affiliated billing organization is SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (NPI: 1770656837; TIN: 205521741) and primary practice location at 62959-5235. Cuartas is affiliated with the IRCCO (ACO ID: A2619) and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Cuartas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 433 traditional Medicare patients, billed 1,577 HCPCS/CPT codes, and received $133,392 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,218 prescription claims across 207 beneficiaries totaling $2,796,313 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 15 claims. Open Payments data shows 2 records totaling $144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing started with an early spike, then settled into a lower baseline, moving from $1,282,286 to $133,392. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $738,383 to $2,796,313. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $16,985 to $7,659.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	567	167,730	$1,282,286
2016	598	143,394	$1,332,528
2017	590	73,571	$620,155
2018	539	34,555	$192,760
2019	491	2,555	$132,319
2020	425	1,589	$106,425
2021	437	1,521	$124,946
2022	449	1,187	$118,285
2023	479	1,449	$155,439
2024	433	1,577	$133,392

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	163	1,159	$738,383
2016	158	1,163	$764,620
2017	154	1,127	$620,687
2018	159	1,235	$1,316,325
2019	145	1,136	$1,393,940
2020	146	1,068	$1,396,237
2021	144	900	$1,041,543
2022	152	883	$1,498,454
2023	213	1,235	$1,921,397
2024	207	1,218	$2,796,313

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	69	473	$20,600
2016	13	177	$7,916
2017	N/R	N/R	N/R
2018	11	33	$2,353
2019	16	132	$16,904
2020	12	12	$1,561
2021	11	13	$1,647
2022	11	16	$2,257
2023	14	15	$2,975
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	18	18	$162
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	166	393	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	18	24	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	377	787	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	160	311	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	35	973	$708,584
Imbruvica	Ibrutinib	18	768	$324,913
Erleada	Apalutamide	22	660	$323,203
Ibrance	Palbociclib	12	329	$190,153
Calquence	Acalabrutinib Maleate	12	360	$186,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$144	Incyte Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alberto Dejesus Cuartas, M.D.?

Tedicare shows public-source Medicare data for Alberto Dejesus Cuartas, M.D. (NPI 1740381169), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alberto Dejesus Cuartas, M.D. have ACO affiliation data?

Alberto Dejesus Cuartas, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Alberto Dejesus Cuartas, M.D.?

Alberto Dejesus Cuartas, M.D. is linked to SOUTHERN ILLINOIS MEDICAL SERVICES, NFP (billing NPI 1770656837) in the available physician profile data.

Does Alberto Dejesus Cuartas, M.D. have Open Payments data?

Alberto Dejesus Cuartas, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.